Conflict of interest: received research funding
Post# of 30028
research funding from Eli Lilly, Ono
Pharmaceuticals, and Amarantus
BioScience for the development of
MANF-based regenerative therapy
for Wolfram syndrome, optic
nerve atrophy, and diabetes
https://df6sxcketz7bb.cloudfront.net/manuscri...188.v2.pdf